您使用提示模式 关闭

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

使用 Cbonds Watchlist 查找、保存和跟踪投资工具

有了 Cbonds Watchlist，您可以随时了解投资信息，做出明智决策！

Watchlist
需要 访问

全选 清除所有
 
(%)
US78464A8707
XBI ISIN
交易所交易基金 (ETF)
基金类型
SPDR State Street Global Advisors
提供商
168,32 USD
每股资产净值 | 2026-08-26
2006-01-31
成立日期
4 每年的次数
股息的支付
CEOILS
CFI
XBI
代码
Formed
Status
Equity
投资项目
Biotech
部门
USA
地区分布
S&P Biotechnology Select Industry Index
基准
0.35 %
总成本比率
12.077,29 百万 USD
基金资产总量 | 2026-08-26
12.077,29 百万 USD
股票类资产 | 2026-08-26
否
UCITS
1 / 3 (11/09/2015)
拆分

收益率 在 2026-08-27, NYSE Arca

  • YTD
    5,06 %
  • 1M
    -7,93 %
  • 3M
    1,65 %
  • 6M
    11,2 %
  • 1Y
    62,15 %
  • 3Y
    51,47 %
  • 5Y
    0,91 %
  • 10Y
    143,19 %
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (XBI)

探索最全面的数据库

1 000 000

债券

100 000

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

结构 XBI 在 2026-08-26

下载结构至 Excel 文档
证券 值
MODERNA INC 2,89%
TWIST BIOSCIENCE CORP 1,97%
APOGEE THERAPEUTICS INC 1,45%
KYMERA THERAPEUTICS INC 1,43%
PRAXIS PRECISION MEDICINES I 1,39%
NATERA INC 1,39%
ORUKA THERAPEUTICS INC 1,38%
HALOZYME THERAPEUTICS INC 1,35%
REVOLUTION MEDICINES INC 1,33%
DIANTHUS THERAPEUTICS INC 1,29%
TRAVERE THERAPEUTICS INC 1,28%
PROTAGONIST THERAPEUTICS INC 1,27%
ERASCA INC 1,27%
CG ONCOLOGY INC 1,27%
SCHOLAR ROCK HOLDING CORP 1,21%
REGENERON PHARMACEUTICALS 1,2%
INSMED INC 1,2%
VAXCYTE INC 1,19%
RHYTHM PHARMACEUTICALS INC 1,16%
AMGEN INC 1,16%
ROIVANT SCIENCES LTD 1,15%
ARROWHEAD PHARMACEUTICALS IN 1,12%
VERTEX PHARMACEUTICALS INC 1,12%
SPYRE THERAPEUTICS INC 1,11%
VIKING THERAPEUTICS INC 1,1%
RELAY THERAPEUTICS INC 1,09%
UNIQURE NV 1,09%
GILEAD SCIENCES INC 1,08%
INCYTE CORP 1,08%
CRISPR THERAPEUTICS AG 1,06%
SELLAS LIFE SCIENCES GROUP I 1,06%
ACADIA PHARMACEUTICALS INC 1,05%
CYTOKINETICS INC 1,05%
TG THERAPEUTICS INC 1,05%
IOVANCE BIOTHERAPEUTICS INC 1,05%
BRIDGEBIO PHARMA INC 1,05%
COGENT BIOSCIENCES INC 1,04%
BIOMARIN PHARMACEUTICAL INC 1,04%
ABBVIE INC 1,04%
KRYSTAL BIOTECH INC 1,02%
MADRIGAL PHARMACEUTICALS INC 1,01%
GRAIL INC 1,01%
BIOGEN INC 1,01%
IMMUNOVANT INC 1,01%
ALKERMES PLC 1%
DYNE THERAPEUTICS INC 0,98%
CELCUITY INC 0,96%
EXELIXIS INC 0,95%
SUMMIT THERAPEUTICS INC 0,95%
MIRUM PHARMACEUTICALS INC 0,93%
IMMUNITYBIO INC 0,92%
BEAM THERAPEUTICS INC 0,91%
PTC THERAPEUTICS INC 0,88%
VERA THERAPEUTICS INC 0,87%
ULTRAGENYX PHARMACEUTICAL IN 0,86%
NEUROCRINE BIOSCIENCES INC 0,86%
IDEAYA BIOSCIENCES INC 0,86%
VIRIDIAN THERAPEUTICS INC 0,85%
UNITED THERAPEUTICS CORP 0,84%
BIOCRYST PHARMACEUTICALS INC 0,84%
SAREPTA THERAPEUTICS INC 0,77%
IMMUNOME INC 0,77%
IONIS PHARMACEUTICALS INC 0,77%
DENALI THERAPEUTICS INC 0,76%
CELLDEX THERAPEUTICS INC 0,73%
ALNYLAM PHARMACEUTICALS INC 0,73%
ARCUS BIOSCIENCES INC 0,71%
DISC MEDICINE INC 0,71%
RECURSION PHARMACEUTICALS A 0,69%
INTELLIA THERAPEUTICS INC 0,68%
ADMA BIOLOGICS INC 0,67%
TANGO THERAPEUTICS INC 0,66%
HYPERLIQUID STRATEGIES 0,65%
ARCUTIS BIOTHERAPEUTICS INC 0,65%
MINERALYS THERAPEUTICS INC 0,65%
SYNDAX PHARMACEUTICALS INC 0,63%
NOVAVAX INC 0,62%
AGIOS PHARMACEUTICALS INC 0,61%
VERACYTE INC 0,59%
NURIX THERAPEUTICS INC 0,59%
BIOHAVEN LTD 0,57%
PALVELLA THERAPEUTICS INC 0,56%
KODIAK SCIENCES INC 0,53%
CAREDX INC 0,52%
XENCOR INC 0,49%
VIR BIOTECHNOLOGY INC 0,49%
CULLINAN THERAPEUTICS INC 0,49%
PRECIGEN INC 0,47%
STOKE THERAPEUTICS INC 0,47%
VERICEL CORP 0,45%
INHIBRX BIOSCIENCES INC 0,45%
ABSCI CORP 0,43%
ANAPTYSBIO INC 0,41%
ORIC PHARMACEUTICALS INC 0,41%
ZENAS BIOPHARMA INC 0,4%
REPLIMUNE GROUP INC 0,39%
CORVUS PHARMACEUTICALS INC 0,39%
AVALO THERAPEUTICS INC 0,37%
VOR BIOPHARMA INC 0,37%
FIRST TRACKS BIOTHERAPEUTICS 0,37%
显示所有 隐藏
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权